首页> 美国卫生研究院文献>Current Health Sciences Journal >Dissolution of Pentoxifylline from Extended Release Formulations. Researches Concerning Development of a Biorelevant Test
【2h】

Dissolution of Pentoxifylline from Extended Release Formulations. Researches Concerning Development of a Biorelevant Test

机译:从延长释放制剂中溶解己酮可可碱。有关生物相关测试发展的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper presents results of a pharmacokinetics study concerning pentoxifylline and its main metabolites after administration of extended release formulation of Trental 400 mg and correlation of this pharmacokinetics with in vitro dissolution test results of parent drug. In order to establish most relevant in vitro test, dissolution was performed in different experimental conditions (stirring rate and dissolution medium). Correlation was linear and very good. Generalization of correlation to rate of appearance of metabolites in plasma proved that this process could be well correlated with dissolution. Most relevant test was finally found to be the release in water medium, in conditions of a high stirring rate – 100 rpm.
机译:本文介绍了戊酸可可碱及其主要代谢产物在特伦特400 mg缓释制剂给药后的药代动力学研究结果,以及该药代动力学与母体药物体外溶出度测试结果的相关性。为了建立最相关的体外测试,在不同的实验条件(搅拌速率和溶出介质)下进行溶出。相关性是线性的,非常好。与血浆中代谢物出现速率的相关性的一般化证明,该过程可以与溶出良好相关。最终,最相关的测试是在高搅拌速率– 100 rpm的条件下在水介质中的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号